https://www.selleckchem.com/products/harmine.html
Vitamin D deficiency is common in HIV population and has been associated with increased comorbidity risk and poor immunologic status. To evaluate the effect of protease inhibitor lopinavir/ritonavir monotherapy on changes in serum 25-hydroxyvitamin D [25(OH)D] over 48 weeks. Thirty-four treatment-naïve HIV individuals initiating lopinavir/ritonavir monotherapy and receiving clinical care from private practice in Houston, Texas, were included. Serum 25-hydroxyvitamin D levels from stored plasma samples collected from IMANI-2 pilot study
Like
Comment
Share
